5 research outputs found
Π‘Π΅Π»Π΅ΠΊΡΠΈΠ²Π½ΡΠ΅ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΡ ΠΊΠ°ΡΠ±ΠΎΠΊΡΠΈΠ»ΡΡΡΠ΅ΡΠ°Π·Ρ Π΄Π»Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ, Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΠΈ ΠΈ ΡΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ², ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΠΈΡΠ½ΡΠ΅ Π³ΡΡΠΏΠΏΡ
In clinical practice, a large number of prodrugs and active drugs containing an ester, carbamate or amide moiety are used. Carboxylesterase (CaE, EC 3.1.1.1) is the key enzyme of hydrolytic metabolism of such drugs in the body, it largely determines their pharmacokinetics, bioavailability, efficacy and possible toxic effects. Using CaE selective inhibitors as components of combined drug therapy it is possible us to regulate the rate of hydrolytic transformation of ester-containing drugs and opens the possibility of their rational use. The development of effective and selective CaE inhibitors suitable for in vivo application is a new promising approach in medicinal chemistry and pharmacology that allows to improve the efficacy, bioavailability and reduce the side effects of ester-containing drugs.Π ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅ ΠΏΡΠΈΠΌΠ΅Π½ΡΠ΅ΡΡΡ Π±ΠΎΠ»ΡΡΠΎΠ΅ ΡΠΈΡΠ»ΠΎ ΠΏΡΠΎΠ»Π΅ΠΊΠ°ΡΡΡΠ² ΠΈ Π°ΠΊΡΠΈΠ²Π½ΡΡ
Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ², ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ
ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΠΈΡΠ½ΡΡ, ΠΊΠ°ΡΠ±Π°ΠΌΠ°ΡΠ½ΡΡ ΠΈΠ»ΠΈ Π°ΠΌΠΈΠ΄Π½ΡΡ Π³ΡΡΠΏΠΏΠΈΡΠΎΠ²ΠΊΡ. ΠΠ»ΡΡΠ΅Π²ΡΠΌ ΡΠ΅ΡΠΌΠ΅Π½ΡΠΎΠΌ Π³ΠΈΠ΄ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌΠ° ΡΠ°ΠΊΠΈΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π² ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ΅ ΡΠ²Π»ΡΡΡΡΡ ΠΊΠ°ΡΠ±ΠΎΠΊΡΠΈΠ»ΡΡΡΠ΅ΡΠ°Π·Ρ (ΠΠ, ΠΠ€ 3.1.1.1), ΠΊΠΎΡΠΎΡΡΠ΅ Π² Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΡΡ ΠΈΡ
ΡΠ°ΡΠΌΠ°ΠΊΠΎΠΊΠΈΠ½Π΅ΡΠΈΠΊΡ, ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠ΅ ΡΠΎΠΊΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΡΡΠ΅ΠΊΡΡ ΡΡΠΈΡ
Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ². ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ΅Π»Π΅ΠΊΡΠΈΠ²Π½ΡΡ
ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠΎΠ² ΠΠ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠΎΠ² ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΡΠ΅Π³ΡΠ»ΠΈΡΠΎΠ²Π°ΡΡ ΡΠΊΠΎΡΠΎΡΡΡ Π³ΠΈΠ΄ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠ΅Π²ΡΠ°ΡΠ΅Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΡΠΎ ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΠΈΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΠΎΠΉ ΠΈ ΠΎΡΠΊΡΡΠ²Π°Π΅Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΈΡ
ΡΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ. Π‘ΠΎΠ·Π΄Π°Π½ΠΈΠ΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ
ΠΈ ΡΠ΅Π»Π΅ΠΊΡΠΈΠ²Π½ΡΡ
ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠΎΠ² ΠΠ Π΄Π»Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ in vivo, ΡΠ²Π»ΡΠ΅ΡΡΡ Π½ΠΎΠ²ΡΠΌ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄ΠΎΠΌ Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ Ρ
ΠΈΠΌΠΈΠΈ ΠΈ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ, ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡΠΈΠΌ ΠΏΠΎΠ²ΡΡΠΈΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ, Π±ΠΈΠΎΠ΄ΠΎΡΡΡΠΏΠ½ΠΎΡΡΡ ΠΈ ΡΠ½ΠΈΠ·ΠΈΡΡ ΠΏΠΎΠ±ΠΎΡΠ½ΡΠ΅ ΡΡΡΠ΅ΠΊΡΡ ΠΌΠ½ΠΎΠ³ΠΎΡΠΈΡΠ»Π΅Π½Π½ΡΡ
Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ², ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ
ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΠΈΡΠ½ΡΠ΅ Π³ΡΡΠΏΠΏΠΈΡΠΎΠ²ΠΊΠΈ
ΠΠ»ΠΈΡΠ½ΠΈΠ΅ ΡΠ°Π·ΠΌΠ΅ΡΠ° ΡΠΈΠΊΠ»Π° ΠΈ ΡΡΡΡΠΊΡΡΡΡ ΡΠΏΠ΅ΠΉΡΠ΅ΡΠ° ΠΊΠΎΠ½ΡΡΠ³Π°ΡΠΎΠ² ΡΠ°ΠΊΡΠΈΠ½Π° ΠΈ Π΅Π³ΠΎ ΡΠΈΠΊΠ»ΠΎΠΏΠ΅Π½ΡΠΈΠ»ΡΠ½ΠΎΠ³ΠΎ Π³ΠΎΠΌΠΎΠ»ΠΎΠ³Π° Ρ 5-(4-ΡΡΠΈΡΡΠΎΡΠΌΠ΅ΡΠΈΠ»-ΡΠ΅Π½ΠΈΠ»Π°ΠΌΠΈΠ½ΠΎ)-1,2,4-ΡΠΈΠ°Π΄ΠΈΠ°Π·ΠΎΠ»ΠΎΠΌ Π½Π° ΡΠΏΠ΅ΠΊΡΡ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ
The conjugates of tacrine and its cyclopentyl analogue with 5-(4-trifluoromethyl-phenylamino)-1,2,4-thiadiazole, combined with two different spacers, pentylaminopropane and pentylaminopropene, were synthesized. Their esterase profile, the ability to displace propidium from the peripheral anionic site (PAS) of acetylcholinesterase (AChE) and antioxidant activity in the ABTS test were investigated. The compounds obtained effectively inhibit cholinesterases with a predominant effect on butyrylcholinesterase, displace propidium from the PAS of Electrophorus electricus AChE (EeAChE) and exhibit a high radical-scavenging capacity. It is shown that, depending on the spacer structure, particulary, the presence of a propenamine or propanamine fragment, the spectrum of biological activity of the conjugates changes.Π‘ΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½Ρ ΠΊΠΎΠ½ΡΡΠ³Π°ΡΡ ΡΠ°ΠΊΡΠΈΠ½Π° ΠΈ Π΅Π³ΠΎ ΡΠΈΠΊΠ»ΠΎΠΏΠ΅Π½ΡΠΈΠ»ΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΎΠ³Π° Ρ 5-(4-ΡΡΠΈΡΡΠΎΡΠΌΠ΅ΡΠΈΠ»-ΡΠ΅Π½ΠΈΠ»Π°ΠΌΠΈΠ½ΠΎ)-1,2,4- ΡΠΈΠ°Π΄ΠΈΠ°Π·ΠΎΠ»ΠΎΠΌ, ΠΎΠ±ΡΠ΅Π΄ΠΈΠ½ΡΠ½Π½ΡΠ΅ Π΄Π²ΡΠΌΡ ΡΠ°Π·Π½ΡΠΌΠΈ ΡΠΏΠ΅ΠΉΡΠ΅ΡΠ°ΠΌΠΈ β ΠΏΠ΅Π½ΡΠΈΠ»Π°ΠΌΠΈΠ½ΠΎΠΏΡΠΎΠΏΠ°Π½ΠΎΠ²ΡΠΌ ΠΈ ΠΏΠ΅Π½ΡΠΈΠ»Π°ΠΌΠΈΠ½ΠΎΠΏΡΠΎΠΏΠ΅Π½ΠΎΠ²ΡΠΌ, ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ ΠΈΡ
ΡΡΡΠ΅ΡΠ°Π·Π½ΡΠΉ ΠΏΡΠΎΡΠΈΠ»Ρ, ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡ Π²ΡΡΠ΅ΡΠ½ΡΡΡ ΠΏΡΠΎΠΏΠΈΠ΄ΠΈΠΉ ΠΈΠ· ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½ΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΡΠ°ΠΉΡΠ° (ΠΠΠ‘) Π°ΡΠ΅ΡΠΈΠ»Ρ
ΠΎΠ»ΠΈΠ½ΡΡΡΠ΅ΡΠ°Π·Ρ (ΠΠ₯Π) ΠΈ Π°Π½ΡΠΈΠΎΠΊΡΠΈΠ΄Π°Π½ΡΠ½Π°Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π² ΡΠ΅ΡΡΠ΅ ΠΠΠ’Π‘. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΡΡΡ Ρ
ΠΎΠ»ΠΈΠ½ΡΡΡΠ΅ΡΠ°Π·Ρ Ρ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΌ Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ΠΌ Π½Π° Π±ΡΡΠΈΡΠΈΠ»Ρ
ΠΎΠ»ΠΈΠ½ΡΡΡΠ΅ΡΠ°Π·Ρ, Π²ΡΡΠ΅ΡΠ½ΡΡΡ ΠΏΡΠΎΠΏΠΈΠ΄ΠΈΠΉ ΠΈΠ· ΠΠΠ‘ ΠΠ₯Π ΠΈΠ· Electrophorus electricus (EeΠΠ₯Π) ΠΈ ΠΎΠ±Π»Π°Π΄Π°ΡΡ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΠ°Π΄ΠΈΠΊΠ°Π»-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠ΅ΠΉ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡΡ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΡΡΡΠΎΠ΅Π½ΠΈΡ ΡΠΏΠ΅ΠΉΡΠ΅ΡΠ°, Π° ΠΈΠΌΠ΅Π½Π½ΠΎ Π½Π°Π»ΠΈΡΠΈΡ Π² Π½Π΅ΠΌ ΠΏΡΠΎΠΏΠ΅Π½Π°ΠΌΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ ΠΈΠ»ΠΈ ΠΏΡΠΎΠΏΠ°Π½Π°ΠΌΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠ°, ΠΌΠ΅Π½ΡΠ΅ΡΡΡ ΡΠΏΠ΅ΠΊΡΡ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΊΠΎΠ½ΡΡΠ³Π°ΡΠΎΠ²
Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics
We investigated the biological activity of a series of substituted chromeno[3,2-c]pyridines, including compounds previously synthesized by our group and novel compounds whose syntheses are reported here. Tandem transformation of their tetrahydropyridine ring under the action of activated alkynes yielding 2-vinylsubstituted chromones was used to prepare nitrogen-containing derivatives of a biologically active chromone system. The inhibitory activity of these chromone derivatives against acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and carboxylesterase (CaE) was investigated using the methods of enzyme kinetics and molecular docking. Antioxidant (antiradical) activity of the compounds was assessed in the ABTS assay. The results demonstrated that a subset of the studied chromone derivatives selectively inhibit BChE but do not exhibit antiradical activity. In addition, the results of molecular docking effectively explained the observed features in the efficacy, selectivity, and mechanism of BChE inhibition by the chromone derivatives. Β© 2018 Elsevier Lt
Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics
We investigated the biological activity of a series of substituted chromeno[3,2-c]pyridines, including compounds previously synthesized by our group and novel compounds whose syntheses are reported here. Tandem transformation of their tetrahydropyridine ring under the action of activated alkynes yielding 2-vinylsubstituted chromones was used to prepare nitrogen-containing derivatives of a biologically active chromone system. The inhibitory activity of these chromone derivatives against acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and carboxylesterase (CaE) was investigated using the methods of enzyme kinetics and molecular docking. Antioxidant (antiradical) activity of the compounds was assessed in the ABTS assay. The results demonstrated that a subset of the studied chromone derivatives selectively inhibit BChE but do not exhibit antiradical activity. In addition, the results of molecular docking effectively explained the observed features in the efficacy, selectivity, and mechanism of BChE inhibition by the chromone derivatives. Β© 2018 Elsevier Lt